ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 748707 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 748707; 2) Community: the network communities that were significantly associated with the response to NSC 748707; 3) Molecule: the relationships between components within communities and NSC 748707; 4) MDR: the compounds that were significantly associated with the NSC 748707.

NSC Compound Enrichment Correlation
NSC 679021 Null 0.0228506033927957 0.38509108
NSC 710525 Null 0.0228506033927957 0.1474975
NSC 718530 Null 0.0228506033927957 0.29142829
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0228506033927957 0.3250927
NSC 740252 Null 0.0228506033927957 0.33020068
NSC 669807 Null 0.0260391472224205 0.40087074
NSC 732179 Null 0.0260391472224205 0.11547567
NSC 750493 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one 0.0260391472224207 0.33765757
NSC 102225 Null 0.0267520285931239 0.26165908
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0267520285931239 0.31314384
Total:83  Current:45    [First] [Prev] [Next] [Last]